Publications by authors named "Erwan Jouannot"

Claim this Profile
T
Two Patient Studies of a Companion Diagnostic Immuno-Positron Emission Tomography (PET) Tracer for Measuring Human CA6 Expression in Cancer for Antibody Drug Conjugate (ADC) Therapy.
Arutselvan Natarajan, Shyam M Srinivas, Carmen Azevedo, Lacey Greene, Anne-Laure Bauchet, Erwan Jouannot

Mol Imaging· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment.
Hélène Bonnevaux, Stephane Guerif, Jana Albrecht, Erwan Jouannot, Thibaud De Gallier

Oncoimmunology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational strategy using multiple nuclear imaging biomarkers to evaluate target engagement and early therapeutic efficacy of SAR439859, a novel selective estrogen receptor degrader.
Laurent Besret, Sébastien d'Heilly, Cathy Aubert, Guillaume Bluet, Florence Gruss-Leleu, Erwan Jouannot

EJNMMI Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput high-volume nuclear imaging for preclinical in vivo compound screening.
Sven Macholl, Ciara M Finucane, Jacob Hesterman, Stephen J Mather, Rachel Pauplis, Erwan Jouannot

EJNMMI Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of 6-[¹⁸F]-fluoromaltose as a novel PET tracer for imaging bacterial infection.
Gayatri Gowrishankar, Mohammad Namavari, Erwan Benjamin Jouannot, Aileen Hoehne, Robert Reeves

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of [¹⁸F]-labelled maltose derivatives as PET tracers for imaging bacterial infection.
Mohammad Namavari, Gayatri Gowrishankar, Aileen Hoehne, Erwan Jouannot, Sanjiv S Gambhir

Mol Imaging Biol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models.
Céline Clémenson, Erwan Jouannot, Ana Merino-Trigo, Chantal Rubin-Carrez, Eric Deutsch

Invest New Drugs· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-frequency ultrasound detection and follow-up of Wilms' tumor in the mouse.
Erwan Jouannot, Jean-Paul Duong-Van-Huyen, Khalil Bourahla, Pascal Laugier, Martine Lelievre-Pegorier

Ultrasound Med Biol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis